I really think AJA is underrated. In my opinion, I'm happy to hold and collect the distributions while waiting for it to reach NTA. I'd suggest everyone do their own analysis and discuss.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025